A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations-Reference-Cited by-同舟云学术

A comparison of four serological assays for detecting anti–SARS-CoV-2 antibodies in human serum samples from different populations

Published:2020-09-02 Issue:559 Volume:12 Page:
ISSN:1946-6234
Container-title:Science Translational Medicine
language:en
Short-container-title:Sci. Transl. Med.

Author:

Grzelak Ludivine¹²³^ORCID,Temmam Sarah⁴^ORCID,Planchais Cyril⁵^ORCID,Demeret Caroline⁶⁷^ORCID,Tondeur Laura⁸,Huon Christèle⁴^ORCID,Guivel-Benhassine Florence¹²,Staropoli Isabelle¹²,Chazal Maxime⁹,Dufloo Jeremy¹²³^ORCID,Planas Delphine¹²^ORCID,Buchrieser Julian¹²^ORCID,Rajah Maaran Michael¹²³^ORCID,Robinot Remy¹²^ORCID,Porrot Françoise¹²^ORCID,Albert Mélanie⁶⁷¹⁰^ORCID,Chen Kuang-Yu¹¹^ORCID,Crescenzo-Chaigne Bernadette⁶⁷^ORCID,Donati Flora⁶⁷¹⁰^ORCID,Anna François¹²,Souque Philippe¹³,Gransagne Marion¹⁴,Bellalou Jacques¹⁵^ORCID,Nowakowski Mireille¹⁵,Backovic Marija¹⁶^ORCID,Bouadma Lila¹⁷¹⁸,Le Fevre Lucie¹⁸,Le Hingrat Quentin¹⁷¹⁹^ORCID,Descamps Diane¹⁷¹⁹^ORCID,Pourbaix Annabelle²⁰,Laouénan Cédric¹⁷²¹^ORCID,Ghosn Jade¹⁷²⁰,Yazdanpanah Yazdan¹⁷²⁰,Besombes Camille⁸,Jolly Nathalie²²^ORCID,Pellerin-Fernandes Sandrine²²,Cheny Olivia²²,Ungeheuer Marie-Noëlle²²,Mellon Guillaume²³^ORCID,Morel Pascal²⁴,Rolland Simon²⁵²⁶^ORCID,Rey Felix A.¹⁶^ORCID,Behillil Sylvie⁶⁷¹⁰^ORCID,Enouf Vincent⁶⁷¹⁰^ORCID,Lemaitre Audrey²⁷^ORCID,Créach Marie-Aude²⁸²⁹^ORCID,Petres Stephane¹⁵^ORCID,Escriou Nicolas¹⁴^ORCID,Charneau Pierre¹²¹³,Fontanet Arnaud⁸³⁰,Hoen Bruno³¹^ORCID,Bruel Timothée¹²^ORCID,Eloit Marc⁴³²^ORCID,Mouquet Hugo⁵^ORCID,Schwartz Olivier¹²^ORCID,van der Werf Sylvie⁶⁷¹⁰^ORCID

Affiliation:

1. Virus and Immunity Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.

2. Vaccine Research Institute, Creteil, France.

3. Université de Paris, Sorbonne Paris Cité, Paris, France.

4. Pathogen Discovery Laboratory, Department of Virology, Institut Pasteur, Paris, France.

5. Laboratory of Humoral Immunology, Department of Immunology, Institut Pasteur, INSERM U1222, Paris, France.

6. Molecular Genetics of RNA Viruses, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.

7. Université de Paris, Paris, France.

8. Emerging Diseases Epidemiology Unit, Department of Global Health, Institut Pasteur, Paris, France.

9. Department of Virology, Institut Pasteur, Paris, France.

10. National Reference Center for Respiratory Viruses, Institut Pasteur, Paris, France.

11. RNA Biology of Influenza Virus, Department of Virology, Institut Pasteur, Paris, France.

12. Pasteur-TheraVectys joined unit, Institut Pasteur, Paris, France.

13. Molecular Virology and Vaccinology Unit, Department of Virology, Institut Pasteur, Paris, France.

14. Innovation lab: Vaccines, Institut Pasteur, Paris, France.

15. Plate-Forme Technologique Production et Purification de Protéines Recombinantes, Institut Pasteur, Paris, France.

16. Structural Virology Unit, Department of Virology, Institut Pasteur, CNRS UMR 3569, Paris, France.

17. Université of Paris, INSERM UMR 1137 IAME, Paris, France.

18. Medical and Infectious Diseases Intensive Care Unit, Assistance Publique-Hôpitaux de Paris, Bichat–Claude-Bernard University Hospital, Paris, France.

19. Department of Virology, Assistance Publique-Hôpitaux de Paris, Bichat–Claude-Bernard University Hospital, Paris, France.

20. Department of Infectious Diseases, Assistance Publique-Hôpitaux de Paris, Bichat–Claude-Bernard University Hospital, Paris, France.

21. Department of Epidemiology, Biostatistics and Clinical Research, Assistance Publique-Hôpitaux de Paris, Bichat–Claude-Bernard University Hospital, INSERM CIC-EC 1425, Paris, France.

22. Investigation Clinique et Accès aux Ressources Biologiques (ICAReB), Center for Translational Research, Institut Pasteur, Paris, France.

23. Unité Coordination du Risque Epidémique et Biologique, AP-HP, Hôpital Necker, Paris, France.

24. Etablissement Français du Sang (EFS), Paris, France.

25. Service de maladies infectieuses, hôpital universitaire Cavale Blanche, Brest, France.

26. CIC 1417, CIC de vaccinologie Cochin-Pasteur, AP-HP, Hôpital Cochin, Paris, France.

27. Direction alerte et crises, réserve sanitaire, Santé publique France, Saint-Maurice, France.

28. Centre d’épidémiologie et de santé publique des armées, Marseille, France.

29. Direction Générale de la Santé, Paris, France.

30. PACRI Unit, Conservatoire National des Arts et Métiers, Paris, France.

31. Direction de la recherche médicale, Institut Pasteur, Paris, France.

32. National Veterinary School of Alfort, Maisons-Alfort, France.

Abstract

Different serological assays measuring anti–SARS-CoV-2 antibodies and their neutralizing activity in samples from individuals with severe and mild COVID-19 are compared.

Funder

Gilead Sciences

Sidaction

Ministère de l’Enseignement supérieur, de la Recherche et de l’Innovation

European Research Council

Agence Nationale de la Recherche

Labex IBEID

Institut Pasteur

CNRS

INSERM

Agence Nationale de Recherches sur le Sida et les Hepatites Virales

REACTing